You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent adult acute myeloid leukemia

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 17, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +23 more
  • Denver, Colorado
  • +2 more
Jun 17, 2021

AML, Adult Recurrent, MDS Trial in United States (LYT-200)

Recruiting
  • AML, Adult Recurrent
  • MDS
  • Los Angeles, California
  • +13 more
Apr 12, 2023

Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

Recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +3 more
  • Fludarabine Phosphate
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 7, 2022

NHL, Adult, AML, Adult Recurrent Trial in Zhengzhou, Tianjin (ETH-155008)

Recruiting
  • NHL, Adult
  • AML, Adult Recurrent
  • Zhengzhou, Henan, China
  • +1 more
Feb 24, 2023

Recurrent Adult Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Worldwide (MEN1112)

Terminated
  • Recurrent Adult Acute Myeloid Leukemia
  • Acute Myeloid Leukemia, in Relapse
  • Antwerp, Belgium
  • +28 more
Jul 5, 2021

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal

Recruiting
  • Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
  • +4 more
  • Chicago, Illinois
    Northwestern University
Apr 30, 2021

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Recurrent Adult Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (drug, biological, other)

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 18, 2021

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Acute Myeloid Leukemia Trial (ABBV-787)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 29, 2023

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 22, 2020

Patients With Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia, Adult
    • Freiburg, CA, Germany
      Medical Center- University of Freiburg
    Aug 4, 2023

    AML, Adult Trial (STI-8591)

    Not yet recruiting
    • AML, Adult
    • (no location specified)
    Jul 12, 2023

    Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      Sep 22, 2023

      Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • Vienna, Austria
      • +3 more
      Jun 8, 2023

      Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 27, 2023

      Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

      Completed
      • Hematopoietic/Lymphoid Cancer
      • +135 more
      • beclomethasone dipropionate
      • +4 more
      • Hackensack, New Jersey
      • +1 more
      Feb 1, 2021

      Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia
      • Aurora, Colorado
        Universtiy of Colorado Hospital
      Aug 22, 2022

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +13 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 2, 2023

      Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Minimal Residual Disease
        • Chapel Hill, North Carolina
          North Carolina Cancer Hospital (NCCH)
        Feb 2, 2023

        Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

        Not yet recruiting
        • Myeloid Malignancies
        • +3 more
        • (no location specified)
        Mar 22, 2023